Adiponectin, IL-6 and hsC-RP in Relation to Carotid Intima-media Thickness in B-thalassemia Patients

NCT03170245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2021-02-16

No results posted yet for this study

Summary

Every year, 100,000 neonates are born with hemoglobinopathies around the world. Thalassemia is the most common heterogeneous disease of the human being . It is a disease of high prevalence in Mediterranean, Indian, North Chinese, and Pacific populations. Recently, the quantity and quality of the life of these patients have been significantly improved by regular transfusion and iron chelating therapy .

Conditions

Interventions

DIAGNOSTIC_TEST

Interleukin-6

serum samples used for doing the test by ELISA

DIAGNOSTIC_TEST

HsC-RP

serum samples used for doing the test by ELISA

DIAGNOSTIC_TEST

Adiponectin level

serum samples used for doing the test by ELISA

DIAGNOSTIC_TEST

Carotid intima media thickness

Done by carotid doppler

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-01-30
Completion
2021-02-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03170245 on ClinicalTrials.gov